Literature DB >> 29272063

Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial.

Anisoara Bumbu1, Abdul Moutairou2,3, Odette Matar1, Frédéric Fumeron2,3, Gilberto Velho2,3, Jean-Pierre Riveline2,3,4, Jean-François Gautier2,3,4, Michel Marre1,2,3, Ronan Roussel1,2,3, Louis Potier1,2,3.   

Abstract

It is unclear whether the frequent non-severe episodes of hypoglycaemia observed during intensive glucose control in individuals with type 1 diabetes (T1D) are associated with subsequent weight gain. We analysed the association between non-severe hypoglycaemia and weight gain in 1441 Diabetes Control and Complication Trial (DCCT) participants. Non-severe hypoglycaemia was assessed by hypo-score (ie, number of blood glucose values <70 mg/dL divided by the total number of measurements during the DCCT quarterly visits). Significant associations were observed between the hypo-score and annual and total weight gain. The annual weight gain by hypo-score tertiles was 0.8 ± 1.2 (T1), 1.3 ± 1.5 (T2) and 1.4 ± 1.3 kg/y (T3), P < .001 for T2 and T3 vs T1, and for T3 vs T2. The odds ratio for a weight gain of 1.8 kg/y was 2.14 (95% CI, 1.56-2.93) for T2, and 2.53 (95%CI, 1.85-3.45) for T3 vs T1. These differences in weight gain and in risk of weight gain remained significant after adjustment for sex, age, duration of diabetes, HbA1c at baseline and treatment arms. In conclusion, our analysis shows a significant association between non-severe hypoglycaemia and weight gain in individuals with T1D from the DCCT.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  glycaemic control; hypoglycaemia; type 1 diabetes; weight gain

Mesh:

Substances:

Year:  2018        PMID: 29272063     DOI: 10.1111/dom.13197

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  5 in total

1.  More hypoglycemia not associated with increasing estimated adiposity in youth with type 1 diabetes.

Authors:  Angelica Cristello Sarteau; Anna R Kahkoska; Jamie Crandell; Daria Igudesman; Karen D Corbin; Jessica C Kichler; David M Maahs; Frank Muntis; Richard Pratley; Michael Seid; Dessi Zaharieva; Elizabeth Mayer-Davis
Journal:  Pediatr Res       Date:  2022-06-22       Impact factor: 3.756

Review 2.  When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD.

Authors:  Alba Rojano-Toimil; Jesús Rivera-Esteban; Ramiro Manzano-Nuñez; Juan Bañares; David Martinez Selva; Pablo Gabriel-Medina; Roser Ferrer; Juan M Pericàs; Andreea Ciudin
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

3.  Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes.

Authors:  Punith Kempegowda; Harbinder Sunsoa; Joht S Chandan; Lauren M Quinn; Prashant M Amrelia; Syed Noman Atta; Sidrah Amir; Yee Suh Teh; Sabba Chaudhry; Anne de Bray; Rifat Rashid; Joanna L Whitehouse; Edward F Nash; Ateeq Syed
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-21       Impact factor: 3.565

4.  Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.

Authors:  Martin Tauschmann; Anke Schwandt; Nicole Prinz; Marianne Becker; Torben Biester; Melanie Hess; Martin Holder; Beate Karges; Andrea Näke; Oliver Kuss; Simone von Sengbusch; Reinhard W Holl
Journal:  Pediatr Diabetes       Date:  2022-02-04       Impact factor: 3.409

5.  Small steps forward: Adjunctive therapy for T1D.

Authors:  Zachary Bloomgarden; Desmond Schatz
Journal:  J Diabetes       Date:  2022-10-07       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.